HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 20-OCT-15 5ECX TITLE KLEBSIELLA PNEUMONIAE DFRA1 COMPLEXED WITH NADPH AND 6-ETHYL-5-(3-(6- TITLE 2 (PYRIDIN-4-YL)BENZO[D][1,3]DIOXOL-4-YL)BUT-1-YN-1-YL)PYRIMIDINE-2,4- TITLE 3 DIAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: DEHYDROFOLATE REDUCTASE TYPE I; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DFRA1,DIHYDROFOLATE REDUCTASE; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: KLEBSIELLA PNEUMONIAE; SOURCE 3 ORGANISM_TAXID: 573; SOURCE 4 GENE: DFRA1; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: DE3; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-41A(+) KEYWDS ANTIFOLATES, DFRA1, PLASMID BORNE RESISTANCE, OXIDOREDUCTASE- KEYWDS 2 OXIDOREDUCTASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.N.LOMBARDO,A.C.ANDERSON REVDAT 6 06-MAR-24 5ECX 1 HETSYN REVDAT 5 11-DEC-19 5ECX 1 REMARK REVDAT 4 18-APR-18 5ECX 1 JRNL REVDAT 3 27-SEP-17 5ECX 1 REMARK REVDAT 2 20-JUL-16 5ECX 1 REMARK REVDAT 1 18-MAY-16 5ECX 0 JRNL AUTH M.N.LOMBARDO,N.G-DAYANANDAN,D.L.WRIGHT,A.C.ANDERSON JRNL TITL CRYSTAL STRUCTURES OF TRIMETHOPRIM-RESISTANT DFRA1 JRNL TITL 2 RATIONALIZE POTENT INHIBITION BY PROPARGYL-LINKED JRNL TITL 3 ANTIFOLATES. JRNL REF ACS INFECT DIS V. 2 149 2016 JRNL REFN ESSN 2373-8227 JRNL PMID 27624966 JRNL DOI 10.1021/ACSINFECDIS.5B00129 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.04 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 28273 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.219 REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.010 REMARK 3 FREE R VALUE TEST SET COUNT : 1983 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.0422 - 4.6971 0.98 2002 142 0.1811 0.2196 REMARK 3 2 4.6971 - 3.7292 0.99 1903 144 0.1655 0.1992 REMARK 3 3 3.7292 - 3.2581 0.99 1890 140 0.2122 0.2189 REMARK 3 4 3.2581 - 2.9604 1.00 1880 142 0.2358 0.3153 REMARK 3 5 2.9604 - 2.7482 0.99 1880 143 0.2559 0.3344 REMARK 3 6 2.7482 - 2.5862 1.00 1864 142 0.2813 0.3518 REMARK 3 7 2.5862 - 2.4568 1.00 1859 144 0.2820 0.3369 REMARK 3 8 2.4568 - 2.3498 1.00 1887 143 0.2732 0.3944 REMARK 3 9 2.3498 - 2.2594 1.00 1857 142 0.2582 0.3589 REMARK 3 10 2.2594 - 2.1814 1.00 1849 137 0.2659 0.3451 REMARK 3 11 2.1814 - 2.1132 1.00 1856 141 0.2642 0.3479 REMARK 3 12 2.1132 - 2.0528 1.00 1853 139 0.2689 0.3437 REMARK 3 13 2.0528 - 1.9988 1.00 1857 142 0.2937 0.3305 REMARK 3 14 1.9988 - 1.9500 1.00 1853 142 0.2990 0.3333 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.000 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 2779 REMARK 3 ANGLE : 1.251 3801 REMARK 3 CHIRALITY : 0.053 414 REMARK 3 PLANARITY : 0.004 468 REMARK 3 DIHEDRAL : 14.759 1047 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5ECX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-OCT-15. REMARK 100 THE DEPOSITION ID IS D_1000214710. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-JAN-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5417 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28273 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 38.040 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 5.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05300 REMARK 200 FOR THE DATA SET : 10.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.45 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 MM IMIDAZOLE, 300 MM CALCIUM REMARK 280 CHLORIDE AND 15 % PEG 6,000, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.97633 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 75.95267 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 75.95267 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 37.97633 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 13970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER B 64 O HOH B 301 2.08 REMARK 500 O HOH A 317 O HOH A 334 2.17 REMARK 500 NE2 GLN B 28 O3 GOL B 203 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 21 46.84 -78.33 REMARK 500 SER A 64 -158.49 -88.33 REMARK 500 PRO B 21 43.07 -81.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 338 DISTANCE = 5.98 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5N1 A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5N1 B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GLV B 204 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5ECC RELATED DB: PDB DBREF 5ECX A 0 156 UNP A4GRC7 A4GRC7_KLEPN 1 157 DBREF 5ECX B 0 156 UNP A4GRC7 A4GRC7_KLEPN 1 157 SEQRES 1 A 157 MET LYS LEU SER LEU MET VAL ALA ILE SER LYS ASN GLY SEQRES 2 A 157 VAL ILE GLY ASN GLY PRO ASP ILE PRO TRP SER ALA LYS SEQRES 3 A 157 GLY GLU GLN LEU LEU PHE LYS ALA ILE THR TYR ASN GLN SEQRES 4 A 157 TRP LEU LEU VAL GLY ARG LYS THR PHE GLU SER MET GLY SEQRES 5 A 157 ALA LEU PRO ASN ARG LYS TYR ALA VAL VAL THR ARG SER SEQRES 6 A 157 SER PHE THR SER ASP ASN GLU ASN VAL LEU ILE PHE PRO SEQRES 7 A 157 SER ILE LYS ASP ALA LEU THR ASN LEU LYS LYS ILE THR SEQRES 8 A 157 ASP HIS VAL ILE VAL SER GLY GLY GLY GLU ILE TYR LYS SEQRES 9 A 157 SER LEU ILE ASP GLN VAL ASP THR LEU HIS ILE SER THR SEQRES 10 A 157 ILE ASP ILE GLU PRO GLU GLY ASP VAL TYR PHE PRO GLU SEQRES 11 A 157 ILE PRO SER ASN PHE ARG PRO VAL PHE THR GLN ASP PHE SEQRES 12 A 157 ALA SER ASN ILE ASN TYR SER TYR GLN ILE TRP GLN LYS SEQRES 13 A 157 GLY SEQRES 1 B 157 MET LYS LEU SER LEU MET VAL ALA ILE SER LYS ASN GLY SEQRES 2 B 157 VAL ILE GLY ASN GLY PRO ASP ILE PRO TRP SER ALA LYS SEQRES 3 B 157 GLY GLU GLN LEU LEU PHE LYS ALA ILE THR TYR ASN GLN SEQRES 4 B 157 TRP LEU LEU VAL GLY ARG LYS THR PHE GLU SER MET GLY SEQRES 5 B 157 ALA LEU PRO ASN ARG LYS TYR ALA VAL VAL THR ARG SER SEQRES 6 B 157 SER PHE THR SER ASP ASN GLU ASN VAL LEU ILE PHE PRO SEQRES 7 B 157 SER ILE LYS ASP ALA LEU THR ASN LEU LYS LYS ILE THR SEQRES 8 B 157 ASP HIS VAL ILE VAL SER GLY GLY GLY GLU ILE TYR LYS SEQRES 9 B 157 SER LEU ILE ASP GLN VAL ASP THR LEU HIS ILE SER THR SEQRES 10 B 157 ILE ASP ILE GLU PRO GLU GLY ASP VAL TYR PHE PRO GLU SEQRES 11 B 157 ILE PRO SER ASN PHE ARG PRO VAL PHE THR GLN ASP PHE SEQRES 12 B 157 ALA SER ASN ILE ASN TYR SER TYR GLN ILE TRP GLN LYS SEQRES 13 B 157 GLY HET NAP A 201 48 HET 5N1 A 202 29 HET NAP B 201 48 HET 5N1 B 202 29 HET GOL B 203 6 HET GLV B 204 5 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM 5N1 6-ETHYL-5-[(3~{S})-3-(6-PYRIDIN-4-YL-1,3-BENZODIOXOL-4- HETNAM 2 5N1 YL)BUT-1-YNYL]PYRIMIDINE-2,4-DIAMINE HETNAM GOL GLYCEROL HETNAM GLV GLYOXYLIC ACID HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN GLV GLYOXALATE; GLYOXYLATE FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 5N1 2(C22 H21 N5 O2) FORMUL 7 GOL C3 H8 O3 FORMUL 8 GLV C2 H2 O3 FORMUL 9 HOH *74(H2 O) HELIX 1 AA1 GLY A 26 TYR A 36 1 11 HELIX 2 AA2 ARG A 44 GLY A 51 1 8 HELIX 3 AA3 SER A 78 THR A 90 1 13 HELIX 4 AA4 GLY A 98 ILE A 106 1 9 HELIX 5 AA5 ASP A 107 VAL A 109 5 3 HELIX 6 AA6 GLY B 26 TYR B 36 1 11 HELIX 7 AA7 ARG B 44 GLY B 51 1 8 HELIX 8 AA8 SER B 78 LYS B 87 1 10 HELIX 9 AA9 GLY B 98 ILE B 106 1 9 HELIX 10 AB1 ASP B 107 VAL B 109 5 3 SHEET 1 AA1 8 VAL A 73 PHE A 76 0 SHEET 2 AA1 8 LYS A 57 VAL A 61 1 N TYR A 58 O LEU A 74 SHEET 3 AA1 8 TRP A 39 GLY A 43 1 N LEU A 40 O ALA A 59 SHEET 4 AA1 8 HIS A 92 VAL A 95 1 O ILE A 94 N TRP A 39 SHEET 5 AA1 8 LYS A 1 SER A 9 1 N SER A 3 O VAL A 95 SHEET 6 AA1 8 THR A 111 ILE A 117 1 O HIS A 113 N LEU A 4 SHEET 7 AA1 8 TYR A 148 LYS A 155 -1 O GLN A 151 N ILE A 114 SHEET 8 AA1 8 PHE A 134 PHE A 142 -1 N VAL A 137 O ILE A 152 SHEET 1 AA2 2 VAL A 13 GLY A 15 0 SHEET 2 AA2 2 VAL A 125 TYR A 126 -1 O VAL A 125 N ILE A 14 SHEET 1 AA3 8 VAL B 73 PHE B 76 0 SHEET 2 AA3 8 LYS B 57 VAL B 61 1 N VAL B 60 O LEU B 74 SHEET 3 AA3 8 TRP B 39 GLY B 43 1 N LEU B 40 O ALA B 59 SHEET 4 AA3 8 HIS B 92 VAL B 95 1 O ILE B 94 N TRP B 39 SHEET 5 AA3 8 LYS B 1 SER B 9 1 N SER B 3 O VAL B 95 SHEET 6 AA3 8 THR B 111 ILE B 117 1 O ILE B 117 N ILE B 8 SHEET 7 AA3 8 TYR B 148 LYS B 155 -1 O SER B 149 N THR B 116 SHEET 8 AA3 8 PHE B 134 PHE B 142 -1 N VAL B 137 O ILE B 152 SHEET 1 AA4 2 VAL B 13 GLY B 15 0 SHEET 2 AA4 2 VAL B 125 TYR B 126 -1 O VAL B 125 N ILE B 14 CISPEP 1 GLY A 97 GLY A 98 0 0.32 CISPEP 2 GLY B 97 GLY B 98 0 -0.02 SITE 1 AC1 28 VAL A 6 ALA A 7 ILE A 14 GLY A 15 SITE 2 AC1 28 GLY A 17 PRO A 18 ASP A 19 ILE A 20 SITE 3 AC1 28 GLY A 43 ARG A 44 LYS A 45 THR A 46 SITE 4 AC1 28 VAL A 61 THR A 62 ARG A 63 SER A 64 SITE 5 AC1 28 PRO A 77 SER A 78 ILE A 79 SER A 96 SITE 6 AC1 28 GLY A 98 GLY A 99 GLU A 100 ILE A 101 SITE 7 AC1 28 TYR A 102 5N1 A 202 HOH A 302 HOH A 315 SITE 1 AC2 12 MET A 5 VAL A 6 ALA A 7 GLU A 27 SITE 2 AC2 12 GLN A 28 PHE A 31 LYS A 32 SER A 49 SITE 3 AC2 12 MET A 50 TYR A 102 SER A 115 NAP A 201 SITE 1 AC3 29 VAL B 6 ALA B 7 ILE B 14 GLY B 17 SITE 2 AC3 29 PRO B 18 ASP B 19 ILE B 20 TRP B 22 SITE 3 AC3 29 GLY B 43 ARG B 44 LYS B 45 THR B 46 SITE 4 AC3 29 VAL B 61 THR B 62 ARG B 63 SER B 64 SITE 5 AC3 29 PRO B 77 SER B 78 SER B 96 GLY B 98 SITE 6 AC3 29 GLY B 99 GLU B 100 ILE B 101 TYR B 102 SITE 7 AC3 29 GLU B 129 5N1 B 202 HOH B 301 HOH B 321 SITE 8 AC3 29 HOH B 332 SITE 1 AC4 17 LYS A 103 MET B 5 VAL B 6 ALA B 7 SITE 2 AC4 17 ILE B 20 GLU B 27 GLN B 28 PHE B 31 SITE 3 AC4 17 LYS B 32 THR B 46 SER B 49 MET B 50 SITE 4 AC4 17 LEU B 53 TYR B 102 SER B 115 NAP B 201 SITE 5 AC4 17 GOL B 203 SITE 1 AC5 4 TRP B 22 GLN B 28 5N1 B 202 HOH B 331 SITE 1 AC6 6 ALA A 143 ASN B 37 GLN B 38 LYS B 57 SITE 2 AC6 6 THR B 90 HOH B 318 CRYST1 76.070 76.070 113.929 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013146 0.007590 0.000000 0.00000 SCALE2 0.000000 0.015179 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008777 0.00000